Skip to main navigation Skip to search Skip to main content

Metabolic syndrome during female midlife: what are the risks?

  • Universidad Católica de Santiago de Guayaquil
  • University of Zaragoza

Research output: Contribution to journal › Review article › peer-review

33 Scopus citations

Abstract

The metabolic syndrome (METS) is an entity diagnosed by three or more of the following factors: abdominal obesity, low high-density lipoprotein cholesterol, and high serum triglycerides, fasting glucose, and/or blood pressure levels. Abdominal obesity is the most prevalent component of the syndrome that favors insulin resistance and a proinflammatory and prothrombotic status, and the risk of developing diabetes, hypertension, and other chronic conditions. During the menopausal transition, women tend to gain weight and this has been related to an increase in the prevalence of the METS. Rates have also been linked to hormonal status (perimenopausal vs. postmenopausal), changes in lifestyle, and endocrine adjustments. Abnormal cytokine secretion subsequently produces endothelial dysfunction, which will consequently increase cardiovascular risk and related morbidity and mortality. This document will review the various risks that arise as a consequence of the METS during female midlife.

Original languageEnglish
Pages (from-to)127-132
Number of pages6
JournalClimacteric
Volume22
Issue number2
DOIs
StatePublished - 4 Mar 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Metabolic syndrome
  • inflammation
  • insulin resistance
  • menopause
  • midlife
  • obesity
  • risks

Fingerprint

Dive into the research topics of 'Metabolic syndrome during female midlife: what are the risks?'. Together they form a unique fingerprint.

Cite this